VNDA earnings

Vanda Pharmaceuticals (VNDA) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.

VNDA earnings history

QuarterReportedEPSEstimateSurpriseRevenue
Q3 2026Oct 28, 2026-0.37-0.6845.75%$69.81M
Q2 2026Aug 5, 2026-1.04-0.58-78.54%$50.53M
Q1 2026May 6, 2026-0.82-0.53-54.72%$51.72M
Q4 2025Feb 11, 2026-2.39-2.18-9.63%$57.22M
Q3 2025Oct 29, 2025-0.38-0.31-22.58%$56.26M
Q2 2025Jul 31, 2025-0.46-0.34-35.29%$52.59M
Q1 2025May 7, 2025-0.50-0.559.09%$50.04M
Q4 2024Feb 13, 2025-0.08-0.1442.86%$53.19M
Q3 2024Nov 6, 2024-0.09-0.1747.06%$47.65M
Q2 2024Jul 31, 2024-0.08-0.2161.90%$50.47M
Q1 2024May 8, 2024-0.070.05-240.00%$47.46M
Q4 2023Feb 7, 2024-0.04-0.0955.56%$45.27M
Q3 2023Nov 8, 20230.000.00100.00%$38.81M
Q2 2023Jul 27, 20230.03-0.13123.08%$46.06M
Q1 2023May 3, 20230.06––$62.50M
Q4 2022Feb 8, 20230.120.0850.00%$64.48M
Q3 2022Nov 2, 20220.060.09-33.33%$65.32M